Last reviewed: May 15, 2026
Last updated: May 15, 2026
Written by:
Jay Hastings,
CEO of PlexusDx
Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance.
Medically reviewed by:
Jayden Lee, PharmD, EMBA
Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.
Ro and Zealthy represent two distinct approaches to telehealth GLP-1 prescribing. Ro launched in 2023 with emphasis on rapid access and brand-name medications like Wegovy and Ozempic, operating through a network of licensed clinicians. Zealthy, established as a precision-focused platform, prioritizes individualized assessments and offers both branded and compounded GLP-1 options, with emphasis on genetic and metabolic context before prescribing. Both serve growing demand for weight management and diabetes support.
Comparing Ro vs Zealthy matters because GLP-1 therapy is not one-size-fits-all. Provider quality, clinical oversight depth, and whether genetic or metabolic screening occurs before prescribing significantly influence safety and efficacy. Ro offers convenience and brand availability; Zealthy emphasizes clinical personalization. PlexusDx extends this precision further by combining compounded GLP-1 options—often more affordable and flexible—with optional Precision Peptide Genetic Testing that may provide context about individual peptide pathway variants.
How Ro and Zealthy Structure Provider Oversight
Ro operates through a network of state-licensed physicians and nurse practitioners who conduct asynchronous consultations. Patients complete health questionnaires, and providers review before issuing prescriptions. Ro does not require in-person visits but does conduct medical reviews. Prescriptions are filled through Ro's pharmacy partners, typically within days.
Zealthy emphasizes synchronous or extended consultations with board-certified clinicians, often with deeper metabolic and genetic assessment protocols built into intake. Zealthy's provider network is smaller and more curated. Zealthy partnerships include compounding pharmacies, allowing flexibility in medication formulation and dosing adjustments. This model prioritizes personalization over speed.
Medication Options and Pharmacy Models
Ro partners primarily with major pharmaceutical brands and specialty pharmacies that dispense Wegovy, Ozempic, Zepbound, and Mounjaro. Ro's strength is brand availability and insurance navigation. Patients typically pay out-of-pocket or use GLP-1 discount programs if uninsured. Typical costs range $300–$500 monthly for branded formulations.
| Factor |
Ro |
Zealthy |
PlexusDx |
| Primary Medication Types |
Brand-name (Wegovy, Ozempic, Zepbound, Mounjaro) |
Branded + Compounded options |
Compounded semaglutide & tirzepatide only (503A pharmacies) |
| Typical Cost Range |
$300–$500/month (brand) |
$129-$369/mo (varies) |
$129–$309/month (compounded, 503A) |
| Genetic or Metabolic Screening |
Standard health questionnaire |
Expanded intake; optional genetic referral |
Optional Precision Peptide Genetic Test ($99 add-on / $298 standalone) |
| Pharmacy Model |
Specialty pharmacy (brand dispensing) |
Mixed (brand + compounding partners) |
Licensed 503A compounding pharmacies only |
Clinical Assessment Depth and Personalization
Ro's standard intake includes weight, BMI, medical history, and medication review. Provider decision is based on FDA eligibility criteria and contraindications. Ro does not routinely offer genetic pathway testing or expanded metabolic profiling. The process is efficient but clinically standardized.
Zealthy's assessment model often includes expanded questions about insulin resistance markers, family history of metabolic disease, prior medication responses, and sometimes optional genetic counseling. This depth supports more tailored dose selection and medication choice. Zealthy providers are encouraged to discuss whether a patient may respond better to semaglutide vs. tirzepatide vs. combination therapies based on clinical presentation.
Price, Insurance, and Access Considerations
Ro typically charges $99–$199 for initial consultations and ongoing provider fees. Medication costs depend on insurance coverage or out-of-pocket brand pricing. Ro's model assumes patients can afford brand-name medications or have insurance that covers them. For uninsured patients, Ro offers GLP-1 savings programs but does not discount compounded alternatives.
Zealthy's pricing is variable and often lower because compounded formulations cost less than branded drugs. Zealthy providers can adjust doses and refill intervals, reducing per-dose cost over time. Zealthy's model aligns with patients seeking affordability alongside clinical personalization. Neither platform emphasizes ultra-low-cost compounded options as a primary offering.
The Role of Genetic Context in Precision GLP-1 Selection
Genetic variants in GLP-1R, GIPR, MC4R, and FTO genes may influence metabolic response and medication sensitivity. Neither Ro nor Zealthy routinely integrates genetic testing into standard workflows, though Zealthy providers may refer patients for testing externally. PlexusDx offers optional Precision Peptide Genetic Testing, which screens for key variants in these peptide-relevant pathways and may help providers contextualize individual responses—not predict exact outcomes, but support clinical conversation.
Safety Monitoring and Follow-Up Protocols
Ro requires baseline cardiovascular and metabolic labs for most patients and recommends follow-up within 4 weeks. Ro monitors for common side effects (nausea, pancreatitis risk, gallbladder issues) through check-in questionnaires. Ro's clinical oversight is competent but does not include routine advanced biomarker monitoring beyond what FDA guidelines require.
Zealthy emphasizes proactive follow-up, often scheduling 2–4 week check-ins and requesting symptom logs. Some Zealthy providers monitor inflammatory markers or lipid shifts during therapy. Zealthy's smaller provider network allows closer relationship and faster response to adverse events or dosing adjustments. Both platforms screen for contraindications, but Zealthy's model includes more granular safety dialogue.
How PlexusDx Supports a More Personalized Approach
PlexusDx does not offer the telehealth or rapid-access model that Ro provides, nor does it position compounded GLP-1 as a substitute for branded medications. Instead, PlexusDx serves patients who prefer working directly with licensed 503A compounding pharmacies and may benefit from personalization support. Compounded semaglutide and tirzepatide through PlexusDx are formulated by state-licensed pharmacists and typically cost 40–50% less than branded alternatives, making them attractive for cost-conscious or uninsured patients.
The Precision Peptide Genetic Test offered by PlexusDx ($99 add-on or $298 standalone) screens for predispositions in GIPR, GLP1R, FTO, and MC4R pathways. This test does not predict exact medication response or guarantee superior outcomes, but may provide context that supports a more informed conversation with a healthcare provider about whether semaglutide, tirzepatide, or combination approaches might align with your genetic profile. Interpretation should always involve a qualified provider.
Patients comparing Ro vs Zealthy should also consider whether compounded GLP-1 options and genetic insight matter to their decision. If affordability is paramount and you value pharmacist-level oversight alongside provider guidance, PlexusDx's 503A compounding network and optional genetic testing may complement a provider conversation. If you prioritize speed, brand access, or asynchronous convenience, Ro remains the faster path. If you seek clinical depth and personalization without the brand premium, Zealthy's model aligns more closely with precision medicine, as does PlexusDx with the added option of genetic context.
How Your Genetics Influence GLP-1 Response
Not everyone responds to GLP-1 medications the same way. Genetic variants — including GIPR rs1800437, GLP1R rs6923761, FTO rs9939609, and MC4R rs17782313 — influence how your body processes these medications, how much weight you lose, and how you tolerate side effects. PlexusDx maps 14 pathways, 49 peptides, and 150+ genetic insights to match each patient to the right medication, dose, and lifestyle protocol for their biology. The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month, or $298 standalone) gives your provider precise insight into your peptide genetic predispositions before the first prescription is written.
Access Personalized GLP-1 Care Through PlexusDx
PlexusDx offers six prescription GLP-1 protocols to all 50 states — no membership, no insurance required, async intake or live consult. The Microdose Glp1 Protocol starts at $129/mo. Medications are dispensed from licensed 503A compounding pharmacies following strict quality and safety standards. Add a Precision Peptide Genetic Test for $99 to personalize your protocol from day one.
Frequently Asked Questions
What is the main difference between Ro and Zealthy?
Ro emphasizes rapid access to brand-name GLP-1 medications through asynchronous provider consultations. Zealthy prioritizes clinical depth and personalization, offering both branded and compounded options with more detailed assessments. Zealthy providers often discuss genetic and metabolic context before prescribing.
Does Ro or Zealthy use genetic testing for GLP-1 selection?
Neither Ro nor Zealthy routinely integrates genetic testing into standard workflows. Zealthy may refer patients externally; Ro does not. PlexusDx offers optional Precision Peptide Genetic Testing that screens for GLP-1–relevant pathway variants and may support provider decision-making without guaranteeing outcomes.
Which is cheaper: Ro or Zealthy?
Zealthy is often cheaper because it includes compounded options ($129-$369/mo vs. Ro's $300–$500 for brands). Zealthy's compounding partnerships also allow dose adjustments that reduce per-dose costs. PlexusDx compounded GLP-1 ranges $129–$309/month through 503A pharmacies, often the most affordable option.
Is compounded GLP-1 as safe as brand-name versions?
Compounded medications from licensed 503A pharmacies follow FDA quality standards and state pharmacy regulations. PlexusDx partners exclusively with 503A compounders, not 503B facilities. Safety depends on quality assurance and provider oversight, not brand status. Discuss risks and benefits with your healthcare provider.
Should I get genetic testing before starting GLP-1 therapy?
Genetic testing is optional and not required. Precision Peptide Genetic Testing through PlexusDx may provide context about peptide pathway predispositions—variants in GLP1R, GIPR, MC4R, FTO—but does not predict exact medication response. Interpretation with a qualified provider supports informed decision-making.
Related Reading
Medical and Editorial Standards
Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.
Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance.
Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.
Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.
Share:
Direct Meds Review: Evaluating Online GLP-1 Safety and Personalization
Orderly Meds Zepbound: Telehealth Access and Compounded GLP-1 Alternatives